As of 2025-07-08, the Relative Valuation of Paratek Pharmaceuticals Inc (PRTK) is (20.93) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.23 USD, the upside of Paratek Pharmaceuticals Inc based on Relative Valuation is -1038.6%.
The range of the Relative Valuation is (20.93) - (19.96) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.3x - 18.2x | 17.8x |
| Forward P/E multiples | 19.1x - 22.0x | 20.4x |
| Fair Price | (20.93) - (19.96) | (20.93) |
| Upside | -1038.4% - -995.2% | -1038.6% |
| Date | P/E |